🇺🇸 FDA
Patent

US 11998568

Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

granted A61KA61K2039/5154A61K2039/5156

Quick answer

US patent 11998568 (Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy) held by Iovance Biotherapeutics, Inc. expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Iovance Biotherapeutics, Inc.
Grant date
Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/55533